Zimmer Partners, LP Immatics N.V. Transaction History
Zimmer Partners, LP
- $5.18 Billion
- Q2 2024
A detailed history of Zimmer Partners, LP transactions in Immatics N.V. stock. As of the latest transaction made, Zimmer Partners, LP holds 360,000 shares of IMTX stock, worth $4.11 Million. This represents 0.08% of its overall portfolio holdings.
Number of Shares
360,000
Previous 397,000
9.32%
Holding current value
$4.11 Million
Previous $4.17 Million
0.26%
% of portfolio
0.08%
Previous 0.09%
Shares
3 transactions
Others Institutions Holding IMTX
# of Institutions
99Shares Held
76.6MCall Options Held
571KPut Options Held
210K-
Rtw Investments, LP New York, NY10MShares$114 Million1.94% of portfolio
-
Wellington Management Group LLP Boston, MA9.54MShares$109 Million0.02% of portfolio
-
Perceptive Advisors LLC New York, NY8.09MShares$92.3 Million2.72% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD7.43MShares$84.8 Million0.05% of portfolio
-
Baker Bros. Advisors LP New York, NY6.44MShares$73.5 Million1.0% of portfolio
About Immatics N.V.
- Ticker IMTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 76,227,000
- Market Cap $870M
- Description
- Immatics N.V., a clinical-stage biopharmaceutical company, focuses on the discovery and development of T cell receptor (TCR) based immunotherapies for the treatment of cancer in the United States. The company is developing targeted immunotherapies with a focus on treating solid tumors through two distinct treatment modalities, such as adoptive c...